Reviews/Dietary Fibre/Fibre lowers all-cause mortality
Systemic · FIBRE-SYS-01 · v2
Borderline: within 4 points of the Likely/Uncertain boundary, so a re-grade could land either side.
Several large population studies tracked how much fibre people ate and whether they later died, and they consistently found that people eating the most fibre died less often during follow-up than those eating the least [21][22][26]. The size of this association grew with the amount of fibre eaten, which strengthens the pattern [21][22][26]. But all of this evidence simply watches what people already eat rather than assigning fibre and comparing outcomes, so healthier eaters may differ in many other ways. Most of these analyses also draw on the same U.S. survey and were all run in people who already had a serious condition such as diabetes, heart disease or advanced ageing, not the general public [21][22][24][26][27]. The panel therefore accepted that the link is real and pointing the same way everywhere, while judging that the corpus cannot show fibre itself causes the lower mortality.
Six cohort analyses with all-cause mortality as an endpoint all point the same direction: more fibre, fewer deaths [21][22][23][24][26][27]. The three most direct report dose-dependent hazard ratios for the highest versus lowest intake, with [21] giving HR 0.65 (95% CI 0.45-0.92), [22] giving HR 0.47 (95% CI 0.37-0.68) at its third quartile, and [26] giving HR 0.58 (95% CI 0.45-0.75) [21][22][26]. Two papers report inflammation as a partial mediator, with [22] attributing 13.07% of the mortality reduction to a fall in its systemic immune-inflammation index [22]. The DASH analysis links higher fibre, magnesium and potassium to lower mortality [27], and the carbohydrate-quality and 26-nutrient analyses flag fibre as a component associated with lower death risk [23][24]. The contested point: The division is whether the uniform signal across cohorts counts as independent replication or as one source repeating itself: five of the six analyses draw on NHANES [21][22][24][26][27], so they share participants, methods and confounding structure. The direction of the association is not in dispute; whether this corpus can carry the causal word 'reduces', and whether a disease-subpopulation finding speaks to the general population, is.
All 28 papers behind this claim with their DOIs and what each does to it, the panel’s arbitration, the evidence gap map and the open research questions. Free, and sent to your inbox.
We’ll also send you other claims from Dietary Fibre, one at a time, and tell you when a release or a pivotal trial changes a grade. Unsubscribe by replying.
One reviewer's only job is to attack the finding. The challenges below were weighed before the grade was set.
The claim verb 'reduces' is causal, but every assessable paper is an observational cohort association; no RCT in the corpus has a mortality endpoint, and residual confounding by overall diet quality and healthy-user behaviour is not excluded.
Apparent replication is largely illusory: [21], [22], [24], [26] and [27] all draw on NHANES, so they share source data, methodology and confounding structure rather than independently replicating the finding.
Where it remains uncertain. Five of six analyses rely on NHANES [21][22][24][26][27] and every study is a high-risk subpopulation, so apparent breadth and replication partly collapse onto one data source.
Aleatory
Even the direct estimates carry sampling spread, e.g. HR 0.65 with CI 0.45-0.92 in [21] and HR 0.58 with CI 0.45-0.75 in [26], so the true effect size is imprecisely bounded.
Epistemic
The corpus contains no randomised trial measuring all-cause mortality; the fibre RCTs present [2][3][9][12][14][16] track inflammation, bowel, glycaemic or blood-pressure markers, leaving the survival question untested by experiment.
Inferential
The verb 'reduces' is causal, but every assessable paper is observational cohort association; healthy-user behaviour and overall diet quality are plausible confounders not eliminated.
The load-bearing papers from a corpus of 28, each classified by what it does to the claim. Every DOI is taken from the corpus the claim was graded on.
Direct dose-related inverse association between total fibre and all-cause mortality in a 9,322-adult NHANES cohort.
“Compared to the lowest quartile, the highest DFI quartile had 35% lower all-cause mortality risk [hazard ratio (HR) = 0.65, 95% confidence interval (CI): 0.45-0.92]”
Panel auditInternal validity: medium · scope of inference: Fiber intake and all-cause mortality in adults with accelerated biological aging.Key limitations: observational · selected subpopulation · self-reported diet · residual confounding
Independent NHANES diabetic cohort confirming a dose-dependent inverse fibre-mortality relationship.
“Higher fiber intake levels demonstrated a dose-dependent inverse relationship with all-cause mortality (P < .001).”
Panel auditInternal validity: medium · scope of inference: Fiber intake and all-cause mortality in U.S. adults with diabetes.Key limitations: observational · diabetic population only · possible threshold effect · self-reported diet
Indirect support: fibre among nutrients associated with reduced mortality in a CKM-syndrome model.
“higher intakes of dietary fiber, choline, vitamin K, and PFA 20:4 were associated with reduced mortality risk”
Panel auditInternal validity: low · scope of inference: Dietary nutrients and mortality in cardiovascular-kidney-metabolic syndrome.Key limitations: no effect size reported · many simultaneous nutrients · observational · CKM-specific population
Independent (PREDIMED) cohort; fibre identified as a main driver of the mortality-linked carbohydrate quality index, but not isolated.
“Dietary fiber and whole-grain intake appeared to be the main CQI components driving these associations.”
Panel auditInternal validity: medium · scope of inference: Carbohydrate quality and mortality in older high-CVD-risk adults.Key limitations: fiber not isolated · composite exposure · observational
4 of 28 papers shown. The full review lists all of them, with the panel’s arbitration →
Claims are graded at each quarterly release, and re-graded between releases only when a pivotal trial lands. Every change is a new version of the claim.
A uniform, dose-responsive associational signal across several cohorts warrants moderate confidence, but the absence of any mortality-endpoint RCT, heavy NHANES non-independence, and subpopulation-only scope hold it short of Likely.
Release 2026-q4 re-graded every claim from its corpus under protocol v0.19. An earlier release's grade is shown for the record; it came from an earlier protocol and is not a movement.
Assumptions that carry weight but are not themselves established.
The panel records the gap that would most move the claim, and the study that would close it.
No randomised mortality trial. The claim's causal verb cannot be supported by observational cohorts alone, and no RCT in the corpus has a mortality endpoint. The panel rates this the highest-importance open gap for the claim, and names the study design that would close it: A long-horizon randomised trial assigning a defined fibre intervention versus usual intake with all-cause mortality as the pre-specified primary endpoint.
Open question: Does increasing dietary fibre intake causally lower all-cause mortality, or does the association reflect confounding by overall diet quality? Why it is still open: The entire assessable corpus [21][22][23][24][26][27] is observational, with no mortality-endpoint RCT to exclude healthy-user confounding.
Priors is a sceptical first reader, not peer review, and not medical advice.
Release 2026-q4 · graded 21 Oct 2026 · protocol v0.19